2023 Meeting News Preview - 1

INSIDE THIS ISSUE
2
2023 Schedule-at-a-Glance
9
Networking and Child Care at SABCS®
10
December 5-9, 2023 | Henry B. Gonzalez Convention Center | San Antonio, TX
PREVIEW EDITION
SABCSMeetingNews.org
2023 SABCS®
here's no better place to
be in December than San
Antonio, where the world's
"
This prestigious
Symposium actively
fosters collaborations
between leading
clinicians and
researchers from
various disciplines
across the globe. The
event facilitates the
exchange of insights
and breakthroughs
in a collaborative
environment that
drives progress
towards the
diagnosis, treatment,
and management of
breast cancer.
Charles Swanton, MB,
PhD, FRS, FAACR, FRCP
preeminent experts in breast cancer
science, care, and advocacy converge
for the San Antonio Breast Cancer
Symposium®. The 2023 SABCS® is
just around the corner, with sessions
beginning on Tuesday, December
5 and culminating with a forum for
career development on Saturday,
December 9.
Now is a great time to secure your
spot at SABCS®, with only one day left
for Advance Registration discounted
rates. Register by October 27 to get a
great rate for the world's best scientific
symposium on breast cancer.
The 2023 SABCS® Program
Planning Committee has developed
a cutting-edge educational and
scientific program, with everything
from clinical workshops and special
sessions to case discussions and
controversies. Topics range from
biology, etiology, and prevention
to diagnosis and novel therapies
of breast cancer and premalignant
breast disease. There is something
for everyone with a special interest in
breast cancer, from patient advocacy
to cellular therapy.
This year's debate topic is
Anthracyclines: To Give or Not to
Give? chaired by Harold J. Burstein,
MD, PhD, Dana-Farber Cancer Institute,
and debated by Martine J. Piccart, MD,
PhD, Institut Jules Bordet, Brussels,
and Virginia F. Borges, MD, University of
Colorado School of Medicine.
ADVANCE REGISTRATION ENDS OCTOBER 27 READ MORE ON PAGE 9 »
What's new at this year's Symposium in San Antonio
BREAST CANCER RESEARCH AND TREATMENTS
are evolving constantly, and so is the scientific program
at the San Antonio Breast Cancer Symposium®.
Whether you are a first-time attendee or an experienced
participant, SABCS® has several new sessions this year,
offering the latest in breast cancer science and research.
STATE-OF-THE-ART SESSIONS
Previously known as Forums, new State-of-the-Art
Sessions will feature late-breaking scientific topics and
discussions on scientific technologies. There are three
sessions scheduled throughout the Symposium.
* Wednesday, December 6, 1:00-2:00 p.m. CT:
Immunotherapy- Purpose, Resistance, and
Toxicity with moderator Sherene Loi, MD, PhD, Peter
MacCallum Cancer Centre, Melbourne, Australia
* Thursday, December 7, 1:00-2:00 p.m. CT:
Implications of Senescence for Breast Cancer
Biology and Treatment with moderator Justin M.
Balko, PharmD, PhD, Vanderbilt University
* Friday, December 8, 1:30-2:30 p.m. CT: Targeting
Mutant ER with moderator Aditya Bardia, MD, MPH,
Massachusetts General Hospital
NEW ABSTRACT CATEGORIES
This year brings a fresh look at abstracts, with all-new
abstract categories and a new location for posters in the
Exhibit Hall to increase visibility during poster sessions.
There will be five total poster sessions throughout the
Symposium, with Poster Spotlight Sessions highlighting
some of the most exciting research submitted this year.
CONTINUED ON PAGE 7 »
: The premier worldwide
event in breast cancer research
T
This year's People's Choice
educational session will be on
Inflammatory Breast Cancer: Clinical
Challenges, Evolving Concepts, and
Novel Treatments.
Many of those highlights can
be found on the first day of the
Symposium, and there is so much
more packed into the following days:
poster spotlights, debates, and clinical
and translational controversies
sessions, along with 11 educational
sessions.
The plenary lectures feature Charles
Swanton, MB, PhD, FRS, FAACR,
FRCP, The Francis Crick Institute,
who will address tumor heterogeneity
and evolution in breast cancer, and
Melinda Telli, MD, Stanford University
School of Medicine, who will discuss
recent advances in triple-negative
breast cancer.
The 2023 SABCS® also will spotlight
surgical and radiation oncology,
with sessions on topics including
demystifying the axilla, patientfriendly
radiation courses with whole
breast irradiation and partial breast
irradiation, and surgical management
of clinical stage I HER2-positive and
triple-negative breast cancer.
This year, the Symposium will
feature new State-of-the-Art Sessions
taking the place of Forums, as well as
abstracts from all-new categories, new
career development workshops, and
a new location for posters. Attendees
will also experience sessions that
are popular year after year, including
CONTINUED ON PAGE 9 »
San Antonio Attractions
SABCS MEETING NEWS
http://SABCSMeetingNews.org https://www.sabcs.org/SABCS-Registration-2023 https://www.sabcs.org/Preliminary-Program-2023 https://www.sabcs.org/Preliminary-Program-2023

2023 Meeting News Preview

Table of Contents for the Digital Edition of 2023 Meeting News Preview

2023 Meeting News Preview - 1
2023 Meeting News Preview - 2
2023 Meeting News Preview - A1
2023 Meeting News Preview - A2
2023 Meeting News Preview - 3
2023 Meeting News Preview - 4
2023 Meeting News Preview - 5
2023 Meeting News Preview - 6
2023 Meeting News Preview - B1
2023 Meeting News Preview - B1
2023 Meeting News Preview - 7
2023 Meeting News Preview - 8
2023 Meeting News Preview - C1
2023 Meeting News Preview - C2
2023 Meeting News Preview - 9
2023 Meeting News Preview - 10
2023 Meeting News Preview - 11
https://www.nxtbook.com/tristareventmedia/SABCS/2023-meeting-news-takeaways
https://www.nxtbook.com/tristareventmedia/SABCS/2023-meeting-news-welcome-edition
https://www.nxtbook.com/tristareventmedia/SABCS/2023-meeting-news-preview
https://www.nxtbookmedia.com